Refine by
Critical Patient Articles & Analysis
148 news found
While approved targeted agents are available to treat several types of oncogenic mutations, patients whose cancers harbor oncogene amplification typically do not derive the same benefit. ...
The ultra-sensitive, personalized MRD assay identifies up to 1,800 somatic variants unique to a patient’s tumor supporting physicians in making informed, individualized management decisions for patients. ...
ByTempus
Together, Tris Pharma and Perigon launched a direct-to-patient program, DYANAVEL Delivered, that allows patients and caregivers to seamlessly access DYANAVEL XR extended-release tablets through Perigon’s digital pharmacy, enhance their medication management, and receive reimbursement assistance and support to help navigate their treatment journey while ...
The HFSA Optimal Medical Therapy in Heart Failure (OMT-HF) program can help your patients achieve their best outcomes. An estimated 6.5 million Americans have heart failure (HF). This year alone another 960,000 will likely be diagnosed with this condition. Chances are several of your patients are in this group. Are they receiving the optimal medical therapy (OMT), that helps them achieve ...
Applying induced pluripotent stem cell (iPSC) technology, patient-cell derived 3D micro tissues exhibiting hereditary cardiac diseases are mass-produced in micro wells. ...
“With darolutamide’s unprecedented survival data and minimal disruption to patients´ daily living across both mHSPC and high risk nmCRPC, following regulatory approval, we will be working to ensure that as many patients as possible benefit from darolutamide. ...
ByBayer AG
Until now, the only other options for these patients were invasive treatments such as lung volume reduction surgery or lung transplantation. ...
“This transforms the nature and scope of our understanding of patient outcomes and is critical to rapidly advancing research and ...
ByxCures
“We believe the onset and duration study is a critical trial for physicians, payers, and patients, and we are delighted that Dr. ...
Illness may also be more common in healthcare settings where staff are interacting with sick patients, which presents an additional challenge to employers in this industry. ...
ByBioVigil
The Ivenix Infusion System from Fresenius Kabi is a large volume infusion pump supported by a management system specifically designed to simplify each step of infusion delivery and help eliminate unnecessary work while informing patient care teams. “To meaningfully impact medication safety, we reimagined the infusion process from beginning to end,” said Susan ...
Current methods to diagnose sepsis take more than 24 hours after a patient enters the emergency ward – by which time, the patient may already be well on their way towards tissue damage, organ failure, and death. ...
New results from the Phase III ARASENS trial evaluating quality of life (QoL) and patient-relevant endpoints for darolutamide plus androgen deprivation therapy (ADT) and docetaxel in patients with metastatic hormone-sensitive prostate cancer (mHSPC) show that, in addition to extending overall survival (OS), darolutamide has a strong tolerability profile and ...
ByBayer AG
Nob Hill is poised to deliver both meaningful therapies to patients and value to its investors. The Nob Hill team has done tremendous work to date, and I look forward to working with them and building on the momentum gained during the last several months." ...
Demonstrated 98% NPV1 to Identify COVID-19 Patients at Risk for Severe Illness Study Data Indicate Symphony IL-6 Test Could be a Rapid and Precise Diagnostic Platform for Near-Patient Management of Critical Care Bluejay Diagnostics, Inc. ...
The Company expects to initiate the trial by the end of 2022 and anticipates dosing the first patient in the trial in the first quarter of 2023. GBM is an aggressive, deadly, and treatment-resistant type of malignant brain tumor, affecting approximately 13,000 newly diagnosed patients each year in the United States. Few treatment options are available for ...
ByCervoMed
“With 90 million people suffering from migraine and nearly 50 million suffering from depression in Greater China and South Korea, we believe this collaboration with NeuroFront is critical to our mission of helping patients globally,” stated Neurolief Chairman Chris Richardson. ...
– IV dislodgement is a near-daily problem for clinicians and their patients, according to a recent focus group of vascular access experts. ...
Engineered to fulfill an unmet clinical need in treating patients suffering from Critical Limb Ischemia (CLI), the Temporary Spur Stent System consists of a unique, retrievable nitinol stent system with radially expandable spikes or “spurs” designed to create channels for increased uptake of antiproliferative drugs (“limus” based) into the ...
” Calantic Digital Solutions is a suite of digital radiology AI-enabled applications which assist radiologists and their teams at critical steps within a patient’s treatment journey. The vendor-neutral, cloud-hosted platform includes a growing number of applications designed to aid in prioritization, lesion detection and quantification, as well as ...
ByBayer AG